Author:
Komrokji Rami,Garcia-Manero Guillermo,Ades Lionel,Prebet Thomas,Steensma David P,Jurcic Joseph G,Sekeres Mikkael A,Berdeja Jesus,Savona Michael R,Beyne-Rauzy Odile,Stamatoullas Aspasia,DeZern Amy E,Delaunay Jacques,Borthakur Gautam,Rifkin Robert,Boyd Thomas E,Laadem Abderrhamane,Vo Bond,Zhang Jennie,Puccio-Pick Marie,Attie Kenneth M,Fenaux Pierre,List Alan F
Reference28 articles.
1. Myelodysplastic syndromes;Adès;Lancet,2014
2. Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management;Garcia-Manero;Am J Hematol,2014
3. International scoring system for evaluating prognosis in myelodysplastic syndromes;Greenberg;Blood,1997
4. Long-term outcome of myelodysplastic syndromes (MDS) patients treated with erythropoiesis stimulating agents (ESAs);Sekeres;Blood,2015
5. National Comprehensive Cancer Network, NCCN Clinical Practice Guidelines in Oncology: myelodysplastic syndromes (version 1.2016). http://www.nccn.org/professionals/physician_gls/pdf/mds.pdf (accessed Oct 19, 2016).
Cited by
100 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献